Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
about
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activityBehavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient micePhenylethylamine, a possible link to the antidepressant effects of exercise?Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.The use of LeptiCore in reducing fat gain and managing weight loss in patients with metabolic syndrome.Credneramides A and B: neuromodulatory phenethylamine and isopentylamine derivatives of a vinyl chloride-containing fatty acid from cf. Trichodesmium sp. nov.In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptorChocolate and health-related quality of life: a prospective study.Exercise and bipolar disorder: a review of neurobiological mediators.Gas chromatographic--mass spectrometric determination of phenylacetic acid in human blood.Effect of a 2-month treatment with Klamin, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women.Lust, attraction, and attachment in mammalian reproduction.Gas chromatography/mass spectrometry based metabolomic study in a murine model of irritable bowel syndrome.
P2860
Q24631419-CCCA696B-6576-4DB8-949A-35972D84670CQ24650165-A0FF0369-1BBF-4E39-A033-83DB5F434172Q28189481-D897DCCD-E552-468A-9023-DCC9474BC768Q30466736-E2A2656C-BC56-4CDC-9472-256E4FA48A8DQ33718565-16DA07E4-1B67-4376-87F4-1CBE8298A77EQ34093372-B7D31BB4-EC88-4B92-A168-DB63CDD590B5Q35182618-29D9E1A2-9B54-4CD6-8512-847E2C10BAD0Q35527016-A2EF7197-5E77-49F1-B72A-6A1AE88598B8Q37569847-36B1EF19-8D0D-48F6-9755-540893334BDBQ45125906-16C0BF7C-8E9E-42C9-826A-C2D5249C2308Q46029241-0A96543D-67BA-4FF5-851C-CD2C6D143B36Q51099129-79501D32-EB27-4A73-B30A-03277A16019DQ52680609-5821F1AC-88F3-4C82-B492-0B3A34A25A02
P2860
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
@ast
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
@en
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
@nl
type
label
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
@ast
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
@en
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
@nl
prefLabel
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
@ast
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
@en
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
@nl
P356
P1476
Phenylethylamine modulation of affect: therapeutic and diagnostic implications.
@en
P2093
P356
10.1176/JNP.7.1.6
P577
1995-01-01T00:00:00Z